UEEC
Price
$0.09
Change
-$0.01 (-10.00%)
Updated
Jul 3 closing price
Capitalization
73.91M
XVIPF
Price
$30.10
Change
+$0.26 (+0.87%)
Updated
Jun 27 closing price
Capitalization
905.23M
Interact to see
Advertisement

UEEC vs XVIPF

Header iconUEEC vs XVIPF Comparison
Open Charts UEEC vs XVIPFBanner chart's image
United Health Products
Price$0.09
Change-$0.01 (-10.00%)
Volume$189.2K
Capitalization73.91M
Xvivo Perfusion AB
Price$30.10
Change+$0.26 (+0.87%)
Volume$100
Capitalization905.23M
UEEC vs XVIPF Comparison Chart in %
Loading...
UEEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
UEEC vs. XVIPF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UEEC is a Hold and XVIPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (UEEC: $0.09 vs. XVIPF: $30.10)
Brand notoriety: UEEC and XVIPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: UEEC: 108% vs. XVIPF: 28%
Market capitalization -- UEEC: $73.91M vs. XVIPF: $905.23M
UEEC [@Medical Specialties] is valued at $73.91M. XVIPF’s [@Medical Specialties] market capitalization is $905.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

UEEC’s FA Score shows that 1 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • UEEC’s FA Score: 1 green, 4 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, UEEC is a better buy in the long-term than XVIPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UEEC’s TA Score shows that 4 TA indicator(s) are bullish while XVIPF’s TA Score has 2 bullish TA indicator(s).

  • UEEC’s TA Score: 4 bullish, 3 bearish.
  • XVIPF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, UEEC is a better buy in the short-term than XVIPF.

Price Growth

UEEC (@Medical Specialties) experienced а -7.82% price change this week, while XVIPF (@Medical Specialties) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($905M) has a higher market cap than UEEC($73.9M). UEEC YTD gains are higher at: 75.330 vs. XVIPF (-26.764). XVIPF has higher annual earnings (EBITDA): 29.2M vs. UEEC (-1.76M). XVIPF has more cash in the bank: 171M vs. UEEC (32K). UEEC has less debt than XVIPF: UEEC (697K) vs XVIPF (27.6M). XVIPF has higher revenues than UEEC: XVIPF (524M) vs UEEC (37.5K).
UEECXVIPFUEEC / XVIPF
Capitalization73.9M905M8%
EBITDA-1.76M29.2M-6%
Gain YTD75.330-26.764-281%
P/E RatioN/A344.83-
Revenue37.5K524M0%
Total Cash32K171M0%
Total Debt697K27.6M3%
FUNDAMENTALS RATINGS
UEEC vs XVIPF: Fundamental Ratings
UEEC
XVIPF
OUTLOOK RATING
1..100
5094
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
6663
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/a27

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UEEC's Valuation (15) in the null industry is significantly better than the same rating for XVIPF (91). This means that UEEC’s stock grew significantly faster than XVIPF’s over the last 12 months.

XVIPF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for UEEC (100). This means that XVIPF’s stock grew somewhat faster than UEEC’s over the last 12 months.

XVIPF's SMR Rating (80) in the null industry is in the same range as UEEC (100). This means that XVIPF’s stock grew similarly to UEEC’s over the last 12 months.

XVIPF's Price Growth Rating (63) in the null industry is in the same range as UEEC (66). This means that XVIPF’s stock grew similarly to UEEC’s over the last 12 months.

XVIPF's P/E Growth Rating (94) in the null industry is in the same range as UEEC (100). This means that XVIPF’s stock grew similarly to UEEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
UEECXVIPF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 5 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
47%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
20%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
UEEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAWX14.610.11
+0.76%
Nationwide GQG US Quality Eq Instl Ser
TRTZX32.130.13
+0.41%
T. Rowe Price Mid-Cap Value Z
VICCX22.170.09
+0.41%
USA Mutuals Vice C
ARYMX13.320.03
+0.23%
American Century Global Real Estate A
TIOSX16.550.02
+0.12%
Nuveen International Opps A

UEEC and

Correlation & Price change

A.I.dvisor tells us that UEEC and SUVPF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UEEC and SUVPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UEEC
1D Price
Change %
UEEC100%
-6.81%
SUVPF - UEEC
20%
Poorly correlated
N/A
SAUHY - UEEC
20%
Poorly correlated
-0.89%
TDSGF - UEEC
9%
Poorly correlated
N/A
VYCO - UEEC
8%
Poorly correlated
N/A
XVIPF - UEEC
4%
Poorly correlated
N/A
More

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and INMD have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and INMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
INMD - XVIPF
20%
Poorly correlated
-0.33%
LUNG - XVIPF
8%
Poorly correlated
+2.21%
VPTDF - XVIPF
7%
Poorly correlated
-6.38%
OM - XVIPF
6%
Poorly correlated
+1.55%
USAQ - XVIPF
4%
Poorly correlated
N/A
More